← Eichor
Condition: Dominant Dystrophic Epidermolysis Bullosa Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Dominant Dystrophic Epidermolysis Bullosa

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Natural History Study of Corneal Abrasions in Patients With Dystrophic Epidermolysis Bullosa (DEB)
Phase N/A · 1 location(s) · Krystal Biotech, Inc. · NCT06563414A Study Comparing KB803 and Matched Placebo in Patients With Dystrophic Epidermolysis Bullosa
Phase 3 · 5 location(s) · Krystal Biotech, Inc. · NCT07016750Long-Term Follow-up Protocol
Phase N/A · 3 location(s) · Krystal Biotech, Inc. · NCT04917887
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.